6[3]Dings J,Meixensberger J,Amschler J,et al.Brain tissue PO2-monitoring in comatose patients:Implications for therapy.J Neurol Res, 1997, 19∶233-240.
7刘明铎主编.实用颅脑损伤学[M].北京：人民军医出版社,1995.71.
8Longstreth WT Jr, lnui TS. High blood glucose level on hospital admission and poor neurological recovery after cardiac arrest. Ann Neurol 1984; 15 ( 1 ) : 59 - 63
9Pulsinelli WA, Levy DE, Sigsbee B, et al. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 1983; 74(4): 540 -4
1Steyerberg EW, Mushkudiani N, Perel P, et al. Predicting out- come after traumatic brain jury: development and internationalvali- datian of prognostic scores based on admission characteristics [ J ]. PLoS Med, 2008, 5(8): 1251-1261.
2Bazan NG. The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling [J]. Cellular Molecular Neurobiol, 2006, 26 (4/6) : B99 - 911.
3Herrmann M, Curio N, Jost S, et al. Release of biochemical makers of damage to neuronal and gial brain tissue is associated with short and lone term neuropsychological outcome after traumatic brain injury [J]. J Neurol Neurosurg Psychiatry, 2001,70(1) : 95 -100.
4Guzel A, Er U, Tatli M, et al. Serum neuron - specific enolase as a predictor of short - term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury[J]. Neurosurg Rev, 2008, 31(4) : 439 -445.
5Chabok SY, Moghadam AD, Saneei Z, et al. Neuron - specific eno- lase and S100B as outcome predictors in severe diffuse axonal injury [J]. J Trauma Acute Care Surg, 20-2, 72(6) : 1654 -1657. 245 -252.
6de Kruijk JR, Leffers P, Menheere PP, eta/. S -100B and neuron - specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls[J]. Aeta Neurol Stand, 2001, 103(3) : 175 -179.
7Johnsson P, Blomquist S, Luhrs C, et al. Neuron - specific enolase increases in plasma during and immediately after extraeorporeal cir- culation [ J ]. Ann Thorac Surg, 2000, 69 ( 3 ) : 750 - 754.
8Franjevic A, Pavicevic R, Bubanovic G, et al. Differences in initial NSE levels in malignant and benign diseases of the thoracic wall [J]. Clin Lab, 2012, 58(3/4) : 245 -252.
9Mondello S, Linnet A, Buki A, et al. Clinical utility of serum levels of ubiquitin C - terminal hydrolase as a biomarker for severe trau- matic brain injury~ J ]. Neurosurgery, 2012, 70 ( 3 ) : 666 - 675.
10Brephy GM, Mondello S, Papa L, et al. Biokinetic analysis of ubiquitin C - terminal hydrelase - L1 ( UCH - L1 ) in severe trau- matic brain injury patient biofluids[ J]. J Neurotranma, 2011, 28 (6) : 861 -870.
